Phage Display Services: Advancing Antibody Discovery & Protein Engineering

Phage Display Services: Advancing Antibody Discovery & Protein Engineering

Phage display is a powerful biotechnology tool used for antibody discovery, protein engineering, and peptide screening. At KS-V Peptide, we provide high-quality phage display services to support research in therapeutics, diagnostics, and drug development.

What is Phage Display?

Phage display is a molecular biology technique where bacteriophages (viruses that infect bacteria) are engineered to express peptides or proteins on their surface. This allows researchers to:

  • Screen large libraries of antibodies, peptides, or proteins
  • Identify high-affinity binders for targets like receptors, antigens, or enzymes
  • Optimize protein interactions for therapeutic and diagnostic applications

Our Phage Display Services

We offer customized phage display solutions, including:

1. Antibody Phage Display

  • Construction of immune/non-immune antibody libraries (scFv, Fab, VHH)
  • Panning & selection against your target antigen
  • High-throughput screening for lead candidates

2. Peptide Phage Display

  • Random or focused peptide libraries for epitope mapping
  • Biopanning to identify bioactive peptides
  • Hit validation via ELISA, SPR, or cell-based assays

3. Protein Engineering & Optimization

  • Affinity maturation to enhance binding strength
  • Stability & solubility improvements for therapeutic proteins
  • Humanization of antibodies for clinical development

Why Choose KS-V Peptide?

✅ High-Diversity Libraries (>10^10 unique clones)
✅ Customized Solutions for your specific target
✅ Fast Turnaround with efficient screening
✅ End-to-End Support from library to leads

Applications

• Therapeutic antibody discovery
• Diagnostic biomarker detection
• Vaccine development
• Protein interaction studies


Partner With Us

Explore our phage display services to accelerate your research.

🔗 Connect with us: KS-V Peptide

hypeptide
http://difficultpeptide.net

Leave a Reply